Nobilis Therapeutics, a clinical stage biotechnology company focused on advancement of innovative CNS therapies, announced today the receipt of a $320K Phase I Small Business Technology Transfer Grant (STTR) from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH). The sponsored research will test the effects of the company’s proprietary […] [Read More]
—–
Source: Weekly Blitz :: Writings
Convert your countries money into Bangladesh taka.
Copyright 2007 The Sylhet Times • Privacy • Legal • Submissions • Suggestions • Contact Us • Site Map • Mobile/PDA • RSS
Comments are closed. Please check back later.